Oncodesign Precision Medicine (OPM) has been awarded a $6.92 million research grant from The Michael J. Fox Foundation (MJFF)…
Andrea Lobo
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo
Japan’s Ministry of Health, Labour and Welfare has granted conditional approval to Amchepry, Sumitomo Pharma’s stem cell-derived therapy designed…
A fully implanted brain device can identify when people with Parkinson’s disease are walking during their everyday lives, according…
The Silvi Foundation has officially launched as a nonprofit organization dedicated to advancing research into Parkinson’s disease and…
The Parkinson’s Foundation has released its new national strategy dedicated to improving care for people with Parkinson’s disease…
The Parkinson’s Foundation and the American College of Sports Medicine (ACSM) are teaming up to make exercise more accessible and…
A Phase 1b clinical trial evaluating Serina Therapeutics’s SER-252 (POZ-apomorphine) in people with advanced Parkinson’s disease has enrolled its…
Depression that starts later in life could be an early clinical manifestation of Parkinson’s disease and the related condition…
Targeting a brain network that links thinking and movement may be an effective treatment strategy for easing motor symptoms in…
Merz Therapeutics North America has launched “Celebrating the Fighters,” a nationwide U.S. community campaign honoring the resiliency and courage…